- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02958605
Smartphone Apps for Pediatric Resuscitation (SMARTER)
Smartphone Medical Applications to Reduce Treatment Dosage Errors in Pediatric Resuscitation; a Randomized Simulation Trial
Medication errors are common in children. Characteristics of errors during critical situations in the Emergency Department are ill-defined and might be more frequent than previously thought. However, optimal strategies to eliminate the risk of prescribing errors remain unknown.
Many smartphone apps have been suggested over the last years with some of them designed to calculate medication dosage for children. The impact of these apps to decrease dosage error has never been evaluated in resuscitation setting.
The aim of the study is to evaluate whether the use of a smartphone application designed to calculate medication doses decreases prescribing errors among residents during pediatric simulated resuscitations.
This will be a crossover-randomized trial using high fidelity simulation among 40 residents rotating in the pediatric emergency department.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T1C5
- CHU Sainte-Justine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Residents (PGY1 to PGY4)
- Completing a rotation in pediatric emergency
Exclusion Criteria:
- Residents who previously participated in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smartphone
Smartphone application
|
If already own a smartphone application dedicated to calculate medication dosage for children, the participant will be allowed to use his/her own application.
Otherwise, the resident will be offered to chose among a list of applications paid by the research team (PediSafe, PediStat, Palm Pedi, Safedose, EZdrip peds).
He/she will be instructed to practice with a few time at home before doing the simulations.
|
Experimental: Handbook
Resuscitation handbook who provides drug dosages for each weight for children.
For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.
|
Resuscitation handbook who provides drug dosages for each weight for children.
For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medication error
Time Frame: During resuscitation
|
The primary outcome is the presence of a medication error.
An error will be defined as a drug dose varying by more than 20% from the recommended dose or by incorrect route.
|
During resuscitation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of tenfold error
Time Frame: During resuscitation
|
A tenfold error will be defined as a drug dose varying by a factor of 10 compared to the recommended dose.
|
During resuscitation
|
Time for prescribing the first medication
Time Frame: During the simulation (10 minutes)
|
Time from the beginning of the simulation and complete prescription (oral or written) of the first medication.
|
During the simulation (10 minutes)
|
Error in bolus medication
Time Frame: during simulation
|
An error in bolus medication will be defined as a drug dose varying by more than 20% from the recommended dose or by incorrect route.
|
during simulation
|
Error in perfusion medication
Time Frame: during simulation
|
An error in perfusion medication will be defined as a drug dose varying by more than 20% from the recommended dose.
This can be related to a preparation error or a flow error.
|
during simulation
|
User satisfaction
Time Frame: 2 weeks
|
Satisfaction of the resident with both tools using a Visual analog scale
|
2 weeks
|
User confidence
Time Frame: 2 weeks
|
Confidence of the resident while using both tools using a Visual analog scale
|
2 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMARTER1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anaphylaxis
-
University of MichiganThe Gerber FoundationRecruiting
-
National Institute of Allergy and Infectious Diseases...RecruitingIdiopathic Anaphylaxis | Drug Anaphylaxis | Venom Anaphylaxis | Food AnaphylaxisUnited States
-
Central Hospital, Nancy, FranceSanofi; GlaxoSmithKline; Zambon SpA; Laboratoires URGO; Pierre Fabre Medicament; Bi... and other collaboratorsUnknownNeuromuscular Blocking Agents AnaphylaxisFrance
-
University of LeedsUnknownExercise AnaphylaxisUnited Kingdom
-
University Hospital, AngersRecruitingAnaphylaxis Caused by Hymenoptera Venom (Disorder)France
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of MedicineCompleted
-
Mahidol UniversityCompletedWheat Allergy | Anaphylaxis Food | Anaphylaxis ExerciseThailand
-
Massachusetts General HospitalWithdrawnAnaphylaxis as a Result of Allergen or Venom ImmunotherapyUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Siriraj HospitalMahidol UniversityCompleted
Clinical Trials on Smartphone apps
-
Ministry of Science and Technology, TaiwanTaipei Hospital, Ministry of Health and WelfareCompleted
-
Northwestern UniversityUniversity of California, San Diego; University of California, Los Angeles; University... and other collaboratorsCompleted
-
University of NottinghamUnknownMild Dementia | Moderate DementiaUnited Kingdom
-
University of ConnecticutUnknown
-
Hong Kong Metropolitan UniversityHealth and Medical Research FundRecruitingAnxiety | Depressive Symptoms | Well-Being, PsychologicalHong Kong
-
University of California, DavisStanford University; Rutgers University; Northeastern UniversityActive, not recruiting
-
Winterlight LabsActive, not recruitingPsychiatric Disorder | Language | SpeechCanada
-
Wake Forest University Health SciencesCompletedCovid19 | Respiratory FailureUnited States
-
Ottawa Hospital Research InstituteTerminated